NOL12 and neoplasm: In a subgroup analysis based on race, sex, age, grade, metastasis status, and stage in the UALCAN database, the transcription level of NOL12 in patients with LIHC was significantly higher than that in normal controls, and the higher the expression of NOL12 was, the later the tumor grading and staging (Figures 1(d)–1(i)).